Smartlab Europe

News

New Tariff Announcement by Trump for Pharma, Patented Drugs

The announcement made by President Donald Trump that his administration is going to impose a 100% tariff on patented pharmaceutical products went on to spark tremendous confusion as government officials, drug companies, and trade groups looked out for clarity...

U.S. Tariff Relief for EU and Japan on Pharmaceuticals

Donald Trump’s new tariffs when it comes to pharmaceutical imports are not going to apply to countries having negotiated agreements with the U.S. that contain the provisions on drugs, as per a White House official, therefore delivering promised tariff...

Five key considerations for biotechs outsourcing biologics manufacturing

Outsourcing is now critical for biotech companies aiming to accelerate their path from discovery to commercialization. Selecting the right contract development and manufacturing (CDMO) partner can influence every aspect of biologics development and manufacturing, from project speed and cost...

How Modern Solutions Are Transforming Dental Care

Dentistry has come a long way from the days of simple checkups and extractions. Today, modern solutions are reshaping the way people experience oral care, combining technology, patient-centered services, and financial accessibility. These changes aren’t just improving outcomes but...

How to Build Long-Term Financial Security Without Sacrificing Your Health Goals

Creating lasting financial security while maintaining your health can feel like a balancing act. On one hand, you want to build wealth, save for the future, and create a financial cushion against life’s uncertainties. On the other hand, you recognize...

FDA Targets Drugmakers with Letters in a Marketing Crackdown

After the FDA went on to state that it was taking on what it has understood to be misleading or deceptive direct-to-consumer pharmaceutical ads, the floodgates have gone on to open, and how? In the first few days post the announcement,...

GSK to Invest $30bn in the U.S. R&D and Manufacturing

GSK plc looks forward to investing $30 billion all across the U.S. in terms of research and development as well as supply chain infrastructure in the next five years. This happens to include a novel $1.2 billion investment when...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »